Purple Biotech (PPBT) Interest Coverage Ratio (2014 - 2026)
Purple Biotech (PPBT) reported Interest Coverage Ratio of 72.61 for Q1 2026, up 80.76% year-over-year from 40.17 in Q1 2025, and down 33.72% quarter-over-quarter from 109.56 in Q4 2025.
Purple Biotech (PPBT) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 12 years of Interest Coverage Ratio data on file, last reported at 72.61 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 72.61, up 80.76% year-over-year; the trailing twelve-month figure through Mar 2026 was 123.04 (up 669.31% YoY), and the FY2025 annual result was 27.96, up 22.72% from the prior year.
- Interest Coverage Ratio eased to 72.61 in Q1 2026 per PPBT's latest filing, from 109.56 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 366.72 in Q4 2022 and troughed at 61.8 in Q2 2025.
- A 5-year average of 127.81 and a median of 86.81 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio surged 9067.33% in 2022, then tumbled 590.82% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 366.72 in 2022, then tumbled by 99.18% to 3.0 in 2023, then plunged by 590.82% to 14.72 in 2024, then jumped by 844.06% to 109.56 in 2025, then tumbled by 33.72% to 72.61 in 2026.
- Business Quant data shows PPBT's Interest Coverage Ratio at 72.61 in Q1 2026, 109.56 in Q4 2025, and 273.4 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | 72.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.61 |
| Dec 31, 2025 | 109.56 |
| Sep 30, 2025 | 273.40 |
| Jun 30, 2025 | -61.80 |
| Mar 31, 2025 | 40.17 |
| Dec 31, 2024 | -14.72 |
| Sep 30, 2024 | 4.17 |
| Jun 30, 2024 | 144.08 |
| Mar 31, 2024 | 262.71 |
| Dec 31, 2023 | 3.00 |
| Sep 30, 2023 | 359.19 |
| Jun 30, 2023 | 34.70 |
| Mar 31, 2023 | 86.81 |
| Dec 31, 2022 | 366.72 |
| Sep 30, 2022 | 317.56 |
| Jun 30, 2022 | -4.18 |
| Mar 31, 2022 | 178.80 |
| Dec 31, 2021 | 68.68 |
| Sep 30, 2021 | -3.54 |
| Jun 30, 2021 | 35.51 |